Autres langues Spectral AI, Inc.

Actions

MDAI

US84757T1051

Equipement et technologie médicale avancés

Temps réel estimé Cboe BZX 17:19:37 23/09/2026			Varia. 5j.	Varia. 1 janv.
1,660 ^USD	0,00%		+7,10%	+16,90%

11/08	Transcript : Spectral AI, Inc., Q2 2026 Earnings Call, Aug 11, 2026
11/08	Spectral AI, Inc. réitère ses prévisions de chiffre d'affaires pour l'exercice clos le 31 décembre 2026	CI

Autres langues

16/09	Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference
01/09	Spectral AI to Present at H.C. Wainwright 28th Annual Global Investment Conference
11/08	Spectral AI Announces 2026 Second Quarter Financial Results
11/08	Spectral Ai, Inc. Reiterates Revenue Guidance for the Year Ending December 31, 2026
11/08	Spectral AI, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
29/07	Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call
08/07	Spectral Ai, Inc. Announces Appointment of Darcy Bajko to Chief Commercial Officer, Effective July 31, 2026
08/07	Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication
29/06	Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell Microcap Value Benchmark Index
29/06	Spectral AI, Inc.(NasdaqCM:MDAI) added to Russell 3000E Value Benchmark
25/06	DeepView® System Highlighted at the 2026 British Burn Association Annual Conference
12/06	Spectral AI Joins the American Board of Wound Management Foundation in Celebrating Wound Healing Awareness Month
11/06	Spectral AI to Participate in 2026 British Burn Association Annual Conference
01/06	Spectral AI Announces Voting Results of Annual Meeting of Stockholders
26/05	Spectral Ai Receives FDA De Novo Clearance for DeepView System for Burn Indication
26/05	Spectral Ai receives FDA De Novo clearance for Deepview® system for burn indication
26/05	Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication
26/05	Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication
12/05	Spectral AI Inc - forecasts FY2026 revenue of about $18.5 million
12/05	Spectral AI Announces 2026 First Quarter Financial Results
12/05	Spectral AI Announces 2026 First Quarter Financial Results
12/05	Spectral AI, Inc. Reiterates Revenue Guidance for the Year Ending December 31, 2026
12/05	Spectral AI, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
30/04	Spectral AI Wins Small Business Innovator Award at Inaugural Texas Innovation Conference
28/04	Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call